Health
Latest stories
Sanofi Sues Eli Lilly for Patent Infringement

French pharmaceutical giant Sanofi has said it is suing U.S. rival Eli Lilly in an American court for infringing four patents relating to its diabetes treatments.

The lawsuit, lodged in the state of Delaware, was triggered by Eli Lilly's notification last month that it plans to ask the U.S. Food and Drug Administration (FDA) for permission to put a new diabetes treatment on the market.

W140 Full Story
Uganda Plans Drug Boost for AIDS Fight

Uganda's government is planning to double expenditure on anti-retroviral drugs in an effort to reverse a worsening trend in HIV infections, a senior health official said Thursday.

The doctor in charge of the health ministry's AIDS control program, Alex Ario, told AFP that over the next year some 1.3 million people will have free access to ARVs, compared to the 600,000 currently being treated.

W140 Full Story
Old Age Futures a Concern in Many Countries

A new study finds that people in nations where the population is aging less swiftly, such as the U.S, are less likely to be worried about their old-age futures than those in parts of Europe and East Asia that are grappling with swiftly shrinking workforces and increasing pension costs.

The survey by the Pew Research Center covers 21 nations.

W140 Full Story
Brain Scans Help Predict Learning Problems

Brain scans may help identify children with learning difficulties much earlier by measuring their short-term memory capacity, according to a Swedish study published Wednesday.

The study by a team of researchers at Karolinska Institute, published in the Journal of Neuroscience, showed that it is possible to map the development of short-term memory capacity with Magnetic Resonance Imaging (MRI scans).

W140 Full Story
Study: Antioxidants Speed Lung Cancer Growth in Mice

People who smoke or have lung cancer should think twice about taking vitamin supplements, according to a Swedish study Wednesday that showed certain antioxidants may make tumors grow faster.

Lab mice that already had cancer were given vitamin E and a drug called acetylcysteine, which sped the growth of their tumors and made them die faster than mice that did not ingest supplements.

W140 Full Story
Stimulants May Prevent Accidents by ADHD Drivers

Adult men with attention deficit hyperactivity disorder may avoid traffic accidents if they take their prescribed medication, said a Swedish study on Wednesday.

The study found that men with ADHD were 45 percent more likely to get into road crashes due to inattentiveness and impulsiveness than men without the disorder.

W140 Full Story
Doctors Use Peanuts to Cure Children of Potentially Fatal Allergy

Doctors said Thursday they could treat peanut allergy by feeding children the very thing their bodies reject, so building tolerance that could save a life in case of accidential ingestion.

Small doses of peanut powder taken over several months seemed to induce tolerance in children with the potentially deadly allergy, a research team wrote Wednesday in The Lancet medical journal.

W140 Full Story
Study: Obesity Among U.S. Kids Starts Early

Obesity among U.S. children is largely established by kindergarten, a study said Wednesday, adding that nearly half of those obese at 14 already had the problem at age five.

The study published in the New England Journal of Medicine also showed that over 14 percent of children enter kindergarten overweight and are four times more likely than normal weight children to become obese by the eighth grade.

W140 Full Story
Transplant Tissue: Stem Cells in 'Revolutionary' Boost

Scientists Wednesday reported a simple way to turn animal cells back to a youthful, neutral state, a feat hailed as a "game-changer" in the quest to grow transplant tissue in the lab.

The research, reported in the journal Nature, could be the third great advance in stem cells -- a futuristic field that aims to reverse Alzheimer's, cancer and other crippling or lethal diseases.

W140 Full Story
Doctors: Too Few Cancer Patients Enroll in Studies

One of every 10 clinical trials for adults with cancer ends prematurely because researchers can't get enough people to test new treatments, scientists report.

The surprisingly high rate reveals not just the scope and cost of wasted opportunities that deprive patients of potential advances, but also the extent of barriers such as money, logistics and even the mistaken fear that people won't get the best care if they join one of these experiments.

W140 Full Story